Clinical Study on Prevention and Treatment of Oral Mucositis in Children

doi:10.13701/j.cnki.kqyxyj.2024.01.002

Abstract

Abstract: Oral mucositis is a common complication in pediatric oncology patients after chemotherapy and radiotherapy treatments, which is characterized by high incidence and tricky prevention and treatment. In recent years, scholars have conducted clinical studies on the safety and efficacy of some methods to prevent and treat oral mucositis in children, such as palifermin, laser, photodynamic therapy, cryotherapy, supersaturated calcium phosphate, chlorhexidine, mucosamin spray, polaprezinc zinc-L-carnosine, honey, and vitamin E. This paper presents a review of clinical studies on the prevention and treatment of oral mucositis in children, with the aim to provide reference for the prevention and treatment of oral mucositis in children.

Key words: oral mucositis, children, prevention and treatment, clinical study

GUO Jincai, ZHOU Honghui. Clinical Study on Prevention and Treatment of Oral Mucositis in Children[J]. Journal of Oral Science Research, 2024, 40(1): 6-10.

References

[1] Larkin HD. Cooling device to prevent chemotherapy oral mucositis gains authorization [J]. JAMA, 2022, 328(21):2101.
[2] Attinà G, Romano A, Maurizi P, et al. Management of oral mucositis in children with malignant solid tumors [J]. Front Oncol, 2021, 11:599243.
[3] Czyzewski K, Debski R, Krenska A, et al. Palifermin in children undergoing autologous stem cell transplantation: a matched-pair analysis [J]. Anticancer Res, 2014, 34(12):7379-7382.
[4] Lucchese A, Matarese G, Manuelli M, et al. Reliability and efficacy of palifermin in prevention and management of oral mucositis in patients with acute lymphoblastic leukemia: a randomized, double-blind controlled clinical trial [J]. Minerva Stomatol, 2016, 65(1):43-50.
[5] Mazhari F, Shirazi AS, Shabzendehdar M. Management of oral mucositis in pediatric patients receiving cancer therapy: A systematic review and meta-analysis [J]. Pediatr Blood Cancer, 2019, 66(3):e27403.
[6] Morris J, Rudebeck M, Neudorf S, et al. Safety, pharmacokinetics, and efficacy of palifermin in children and adolescents with acute leukemias undergoing myeloablative therapy and allogeneic hematopoietic stem cell transplantation: A pediatric blood and marrow transplant consortium trial [J]. Biol Blood Marrow Transplant, 2016, 22(7):1247-1256.
[7] 张琳琳,迟昨非,顾敏,等.重组人粒细胞巨噬细胞刺激因子联合重组表皮生长因子治疗儿童急性白血病化疗性口腔黏膜炎的临床疗效分析[J].中国实用儿科杂志,2022,37(11):857-860.
[8] Vitale MC, Modaffari C, Decembrino N, et al. Preliminary study in a new protocol for the treatment of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT) [J]. Lasers Med Sci, 2017, 32(6):1423-1428.
[9] Hafner D, Hrast P, Tomaevi T, et al. Photobiomodulation for chemotherapy-induced oral mucositis in pediatric patients [J]. Biomolecules, 2023, 13(3):418.
[10] Gobbo M, Verzegnassi F, Ronfani L, et al. Multicenter randomized, double-blind controlled trial to evaluate the efficacy of laser therapy for the treatment of severe oral mucositis induced by chemotherapy in children: laMPO RCT [J]. Pediatr Blood Cancer, 2018, 65(8):e27098.
[11] He M, Zhang B, Shen N, et al. A systematic review and meta-analysis of the effect of low-level laser therapy (LLLT) on chemotherapy-induced oral mucositis in pediatric and young patients [J]. Eur J Pediatr, 2018, 177(1):7-17.
[12] Tomaevi T, Potonik U, Cizerl D, et al. Optimization of photobiomodulation protocol for chemotherapy-induced mucositis in pediatric patients [J]. Photobiomodul Photomed Laser Surg, 2020, 38(8):466-471.
[13] Castro JF, Abreu EG, Correia AV, et al. Low-level laser in prevention and treatment of oral mucositis in pediatric patients with acute lymphoblastic leukemia [J]. Photomed Laser Surg, 2013, 31(12):613-618.
[14] Ribeiro VC, Motta Silveira FM, Barbosa Monteiro MG, et al. Photodynamic therapy for treatment of oral mucositis: Pilot study with pediatric patients undergoing chemotherapy [J]. Photodiagnosis Photodyn Ther, 2018, 21:115-120.
[15] Al-Rudayni AHM, Gopinath D, Maharajan MK, et al. Efficacy of oral cryotherapy in the prevention of oral mucositis associated with cancer chemotherapy: Systematic review with meta-analysis and trial sequential analysis [J]. Curr Oncol, 2021, 28(4):2852-2867.
[16] Kawaguchi K, Umeda K, Takachi T, et al. Effects of cryotherapy on high-dose melphalan-induced oral mucositis in pediatric patients undergoing autologous stem cell transplantation [J]. Pediatr Blood Cancer, 2020, 67(9):e28495.
[17] Kamsvåg T, Svanberg A, Legert KG, et al. Prevention of oral mucositis with cryotherapy in children undergoing hematopoietic stem cell transplantations-a feasibility study and randomized controlled trial [J]. Support Care Cancer, 2020, 28(10):4869-4879.
[18] Shahrabi M, Solduzian M, Babaie MH, et al. The effects of a combination oral spray (Mucosamin^®) for the prevention of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: a double blind randomized clinical trial [J]. Support Care Cancer, 2022, 30(10):7963-7972.
[19] Mubaraki S, Pani SC, Alseraihy A, et al. The efficacy of two different oral hygiene regimens on the incidence and severity of oral mucositis in pediatric patients receiving hematopoietic stem cell transplantation: A prospective interventional study [J]. Spec Care Dentist, 2020, 40(6):566-573.
[20] Treister N, Nieder M, Baggott C, et al. Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation [J].Br J Cancer, 2017, 116(1):21-27.
[21] Immonen E, Aine L, Nikkilä A, et al. Randomized controlled and double-blinded study of Caphosol versus saline oral rinses in pediatric patients with cancer [J]. Pediatr Blood Cancer, 2020, 67(10):e28520.
[22] Funato M, Ozeki M, Suzuki A, et al. Prophylactic effect of polaprezinc, a Zinc-L-carnosine, against chemotherapy-induced oral mucositis in pediatric patients undergoing autologous stem cell transplantation [J]. Anticancer Res, 2018, 38(8):4691-4697.
[23] Raether D, Walker PO, Bostrum B, et al. Effectiveness of oral chlorhexidine for reducing stomatitis in a pediatric bone marrow transplant population [J]. Pediatr Dent, 1989, 11(1):37-42.
[24] Costa EM, Fernandes MZ, Quinder LB, et al. Evaluation of an oral preventive protocol in children with acute lymphoblastic leukemia [J]. Pesqui Odontol Bras, 2003, 17(2):147-150.
[25] Cheng KK, Chang AM. Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy [J]. Cancer Nurs, 2003, 26(6):476-484.
[26] Zhang L, Yin Y, Simons A, et al. Use of honey in the management of chemotherapy-associated oral mucositis in paediatric patients [J]. Cancer Manag Res, 2022, 14:2773-2783.
[27] Al Jaouni SK, Al Muhayawi MS, Hussein A, et al. Effects of honey on oral mucositis among pediatric cancer patients undergoing chemo/radiotherapy treatment at King Abdulaziz University Hospital in Jeddah, Kingdom of Saudi Arabia [J]. Evid Based Complement Alternat Med, 2017, 2017:5861024.
[28] Hao S, Ji L, Wang Y. Effect of honey on pediatric radio/chemotherapy-induced oral mucositis (R/CIOM): A systematic review and meta-analysis [J]. Evid Based Complement Alternat Med, 2022, 2022:6906439.
[29] Yarom N, Hovan A, Bossi P, et al. Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines-part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents [J]. Support Care Cancer, 2020, 28(5):2457-2472.
[30] Konuk Sener D, Aydin M, Cangur S, et al. The effect of oral care with chlorhexidine, vitamin E and honey on mucositis in pediatric intensive care patients: A randomized controlled trial [J]. J Pediatr Nurs, 2019, 45:e95-e101.